These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 31612267)

  • 1. Neutrophil elastase contributes to the pathological vascular permeability characteristic of diabetic retinopathy.
    Liu H; Lessieur EM; Saadane A; Lindstrom SI; Taylor PR; Kern TS
    Diabetologia; 2019 Dec; 62(12):2365-2374. PubMed ID: 31612267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoreceptor cells produce inflammatory products that contribute to retinal vascular permeability in a mouse model of diabetes.
    Tonade D; Liu H; Palczewski K; Kern TS
    Diabetologia; 2017 Oct; 60(10):2111-2120. PubMed ID: 28755268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
    Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
    Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
    Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
    Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nox (NADPH Oxidase) 1, Nox4, and Nox5 Promote Vascular Permeability and Neovascularization in Retinopathy.
    Deliyanti D; Alrashdi SF; Touyz RM; Kennedy CR; Jha JC; Cooper ME; Jandeleit-Dahm KA; Wilkinson-Berka JL
    Hypertension; 2020 Apr; 75(4):1091-1101. PubMed ID: 32114846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy.
    Kim D; Mecham RP; Nguyen NH; Roy S
    Exp Eye Res; 2019 Jul; 184():221-226. PubMed ID: 31022398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cKit Inhibitor, Masitinib, Prevents Diabetes-Induced Retinal Vascular Leakage.
    Kim SR; Im JE; Jeong JH; Kim JY; Kim JT; Woo SJ; Sung JH; Park SG; Suh W
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1201-6. PubMed ID: 26978025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin Attenuates Retinal Vascular Leakage by Inhibiting Calcium/Calmodulin-Dependent Protein Kinase II Activity in Streptozotocin-Induced Diabetes.
    Li J; Wang P; Ying J; Chen Z; Yu S
    Cell Physiol Biochem; 2016; 39(3):1196-208. PubMed ID: 27595397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes.
    Lee VK; Hosking BM; Holeniewska J; Kubala EC; Lundh von Leithner P; Gardner PJ; Foxton RH; Shima DT
    Diabetologia; 2018 Nov; 61(11):2422-2432. PubMed ID: 30094465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing Nogo-B improves the integrity of blood-retinal barrier in diabetic retinopathy via regulating Src, PI3K/Akt and ERK pathways.
    Yang Q; Zhang C; Xie H; Tang L; Liu D; Qiu Q; Luo D; Liu K; Xu JY; Tian H; Lu L; Xu GT; Zhang J
    Biochem Biophys Res Commun; 2021 Dec; 581():96-102. PubMed ID: 34662809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes-mediated IL-17A enhances retinal inflammation, oxidative stress, and vascular permeability.
    Sigurdardottir S; Zapadka TE; Lindstrom SI; Liu H; Taylor BE; Lee CA; Kern TS; Taylor PR
    Cell Immunol; 2019 Jul; 341():103921. PubMed ID: 31076079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement of NOX2 expression in both retina and bone marrow for diabetes-induced retinal vascular injury.
    Rojas M; Zhang W; Xu Z; Lemtalsi T; Chandler P; Toque HA; Caldwell RW; Caldwell RB
    PLoS One; 2013; 8(12):e84357. PubMed ID: 24358357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of protein kinase C-ζ attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy.
    Song HB; Jun HO; Kim JH; Yu YS; Kim KW; Kim JH
    Biochem Biophys Res Commun; 2014 Jan; 444(1):63-8. PubMed ID: 24434146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy.
    Rangasamy S; Srinivasan R; Maestas J; McGuire PG; Das A
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3784-91. PubMed ID: 21310918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF-B prevents chronic hyperglycemia-induced retinal vascular leakage by regulating the CDC42-ZO1/VE-cadherin pathway.
    Xu Y; Peng Y; Wu X; Ni F; Sun D; Zhang P; Yang Y; Yan M; Mi J; Tian G
    FASEB J; 2024 Sep; 38(17):e70019. PubMed ID: 39215561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELOVL4-Mediated Production of Very Long-Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability.
    Kady NM; Liu X; Lydic TA; Syed MH; Navitskaya S; Wang Q; Hammer SS; O'Reilly S; Huang C; Seregin SS; Amalfitano A; Chiodo VA; Boye SL; Hauswirth WW; Antonetti DA; Busik JV
    Diabetes; 2018 Apr; 67(4):769-781. PubMed ID: 29362226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the blockade of the IL-23-Th17-IL-17A pathway on streptozotocin-induced diabetic retinopathy in rats.
    Xu H; Cai M; Zhang X
    Graefes Arch Clin Exp Ophthalmol; 2015 Sep; 253(9):1485-92. PubMed ID: 25371107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of X-box binding protein 1 in Müller cells augments retinal inflammation in a mouse model of diabetes.
    Yang J; Chen C; McLaughlin T; Wang Y; Le YZ; Wang JJ; Zhang SX
    Diabetologia; 2019 Mar; 62(3):531-543. PubMed ID: 30612139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirt1: A Guardian of the Development of Diabetic Retinopathy.
    Mishra M; Duraisamy AJ; Kowluru RA
    Diabetes; 2018 Apr; 67(4):745-754. PubMed ID: 29311218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.